The polymorphisms of the MMP-1 and the MMP-3 genes and the risk of pelvic organ prolapse

International Urogynecology Journal and Pelvic Floor Dysfunction

Volumn 24, Issue 6, 2013, Pages 1033-1038

  Skorupski, Paweł ^a   Jankiewicz, Katarzyna ^a   Miotła, Paweł ^a   Marczak, Małgorzata ^b   Kulik Rechberger, Beata ^a   Rechberger, Tomasz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

MMP 1; MMP 3; Pelvic organ prolapse; Polymorphism

Indexed keywords

INTERSTITIAL COLLAGENASE; STROMELYSIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 1 GENE; MATRIX METALLOPROTEINASE 3 GENE; MOLECULAR PATHOLOGY; PELVIC ORGAN PROLAPSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PELVIC ORGAN PROLAPSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84879083035     PISSN: 09373462     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-012-1970-1     Document Type: Article

References (31)

1. Samuelsson EC, Victor FT, Tibblin G, Svärdsudd KF (1999) Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol 180:299-305
2. Swift S, Woodman P, O'Boyle A, Kahn M, Valley M, Bland D, Wang W, Schaffer J (2005) Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 192:795-806
3. Gelse K, Pöschl E, Aigner T (2003) Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev 55:1531-1546
4. Murphy G, Nagase H (2008) Progress in matrix metalloproteinase research. Mol Aspects Med 29:290-308
5. Jack GS, Nikolova G, Vilain E, Raz S, Rodríguez LV (2006) Familial transmission of genitovaginal prolapse. Int Urogynecol J Pelvic Floor Dysfunct 17:498-501
6. Altman D, Forsman M, Falconer C, Lichtenstein P (2008) Genetic influence on stress urinary incontinence and pelvic organ prolapse. Eur Urol 54:918-922
7. Dietz HP, Hansell NK, Grace ME, Eldridge AM, Clarke B, Martin NG (2005) Bladder neck mobility is a heritable trait. BJOG 112:334-339
8. Mann V, Hobson EE, Li B, Stewart TL, Grant SF, Robins SP, Aspden RM, Ralston SH (2001) A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107:899-907
9. Wang J, Xu D, Wu X, Zhou C, Wang H, Guo Y, Cao K (2011) Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis. Heart 97:1542-1546
10. Liu D, Duan W, Guo H, Xu X, Bai Y (2011) Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer. Int J Colorectal Dis 26:1099-1105
11. Skorupski P, Król J, Starega J, Adamiak A, Jankiewicz K, Rechberger T (2006) An alpha-1 chain of type I collagen Sp1-binding site polymorphism in women suffering from stress urinary incontinence. Am J Obstet Gynecol 194:346-350
12. Spurr NK, Gough AC, Gosden J, Rout D, Porteous DJ, van Heyningen V, Docherty AJ (1988) Restriction fragment length polymorphism analysis and assignment of the metalloproteinases stromelysin and collagenase to the long arm of chromosome 11. Genomics 2:119-127
13. Curry TE Jr, Osteen KG (2001) Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 64:1285-1296
14. Quinones S, Buttice G, Kurkinen M (1994) Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1. Biochem J 302:471-477
15. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ (1987) Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J 248:265-268
16. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271:13055-13060
17. Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10-17
18. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61:7825-7829
19. Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, Wang Y, Wen D, Wei L, Zhang J (2005) Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 26:481-486
20. Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI (2004) Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res 10:8229-8234
21. Lai HC, Chu CM, Lin YW, Chang CC, Nieh S, Yu MH, Chu TY (2005) Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer. Gynecol Oncol 96:314-319
22. Checa M, Ruiz V, Montaño M, Velázquez-Cruz R, Selman M, Pardo A (2008) MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum Genet 124:465-472
23. Okamoto K, Mimura K, Murawaki Y, Yuasa I (2005) Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J Gastroenterol Hepatol 20:1102-1108
24. Zucker S, Vacirca J (2004) Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23:101-117
25. Humphries S, Bauters C, Meirhaeghe A, Luong L, Bertrand M, Amouyel P (2002) The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J 23:721-725
26. Vishwajit S, Rohozinski J, Andersson K-E, Badlani G (2009) Association of MMP-1 promoter variant with stress urinary incontinence and pelvic organ prolapse in women. J Urol 181 [4 Suppl]:481
27. Ferrari MM, Rossi G, Biondi ML, Viganò P, Dell'utri C, Meschia M (2012) Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse. Arch Gynecol Obstet 285:1581-1586
28. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R (2002) A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res 8:3820-3823
29. Djurić T, Zivković M, Radak D, Jekić D, Radak S, Stojković L, Raicević R, Stanković A, Alavantić D (2008) Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Clin Biochem 41:1326-1329
30. Zheng H, Si Z, Kasperk R, Bhardwaj RS, Schumpelick V, Klinge U, Klosterhalfen B (2002) Recurrent inguinal hernia: disease of the collagen matrix? World J Surg 26:401-408
31. Alakus H, Afriani N, Warnecke-Eberz U, Bollschweiler E, Fetzner U, Drebber U, Metzger R, Hölscher AH, Mönig SP (2010) Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. World J Surg 34:2853-2859